TN2013000247A1 - Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer - Google Patents

Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer

Info

Publication number
TN2013000247A1
TN2013000247A1 TNP2013000247A TN2013000247A TN2013000247A1 TN 2013000247 A1 TN2013000247 A1 TN 2013000247A1 TN P2013000247 A TNP2013000247 A TN P2013000247A TN 2013000247 A TN2013000247 A TN 2013000247A TN 2013000247 A1 TN2013000247 A1 TN 2013000247A1
Authority
TN
Tunisia
Prior art keywords
inhibitor
compositions
treating cancer
mek
pi3k
Prior art date
Application number
TNP2013000247A
Other languages
French (fr)
Inventor
Laurent Debussche
Carlos Garcia-Escheverria
Jianguo Ma
Stuart Mcmillan
Janet Anne Meurer Ogden
Loic Vincent
Original Assignee
Sanofi Sa
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/063871 external-priority patent/WO2012078832A1/en
Application filed by Sanofi Sa, Merck Patent Gmbh filed Critical Sanofi Sa
Publication of TN2013000247A1 publication Critical patent/TN2013000247A1/en

Links

Abstract

Methods of treating patients with cancer are provided, wherein the methods comprise administering to the patient an effective amount of a MEK inhibitor and an effective amount of a PI3K inhibitor. Compositions in which the MEK and PI3K inhibitors are combined also are described.
TNP2013000247A 2011-03-25 2013-06-07 Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer TN2013000247A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161467485P 2011-03-25 2011-03-25
PCT/US2011/063871 WO2012078832A1 (en) 2010-12-09 2011-12-08 Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer

Publications (1)

Publication Number Publication Date
TN2013000247A1 true TN2013000247A1 (en) 2014-11-10

Family

ID=54359567

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000247A TN2013000247A1 (en) 2011-03-25 2013-06-07 Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer

Country Status (1)

Country Link
TN (1) TN2013000247A1 (en)

Similar Documents

Publication Publication Date Title
TN2013000508A1 (en) Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
MY183661A (en) Treatment of cancer with tor kinase inhibitors
MX2013006319A (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer.
PH12014502048B1 (en) Treatment of cancer with tor kinase inhibitors
PH12014501639A1 (en) Pharmaceutical compositions and methods
PH12014502029B1 (en) Treatment of cancer with tor kinase inhibitors
MX2013003076A (en) Breast cancer therapeutics.
PH12014502046A1 (en) Treatment of cancer with tor kinase inhibitors
PH12015500867B1 (en) Treatment of prostate cancer with tor kinase inhibitors
MX2019008817A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
MX354383B (en) Systems, methods, and formulations for treating cancer.
MX2014010940A (en) The use of antithrombin in the treatment of pre-eclampsia.
IN2014DN00123A (en)
TN2014000418A1 (en) Methods for treating cancer using pi3k inhibitor and mek inhibitor
BR112015005392A2 (en) tablet formulation of a phosphatidylinositol 3 kinase inhibitor
TN2013000247A1 (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer
CO6721062A2 (en) Cmpositions and methods to treat cancer using a pi3k inhibitor and a mek inhibitor
ECSP13012736A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
NI201300052A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND A MEK INHIBITOR
GT201300148A (en) COMPOSITIONS AND METHODS TO TREAT CANCER USING A P13K INHIBITOR AND A MEK INHIBITOR